Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Macrocyclic inhibitors of hepatitis C virus NS3-serine protease

Macrocyclic inhibitors of hepatitis C virus NS3-serine protease

US Patent 7592419 · Granted Sep 22, 2009

Estimated economic value: $105,264,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Matriptase 2 inhibitors and uses thereof2025
Oxazolidinone compounds and methods of use thereof as antibacterial agents2025
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharm2025
Spirotricycle RIPK1 inhibitors and methods of uses thereof2024
TrkA antibody and application thereof2024
Chromane amidine monobactam compounds for the treatment of bacterial infections2024
Benzimidazoles and indoles as taro inhibitors2023
Oxazolidinones as TarO inhibitors2023
Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists2021
Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists2021
Benzimidazoles and indoles as taro inhibitors2021
Oxazolidinones as taro inhibitors2021